- Global Pharma News & Resources

Pelvic Floor Stimulators Market exhibit CAGR of 8.8% for 2021–2031, reaching US$ 274.9 Mn by 2031: Future Market Insights Study

Increasing demand for electrical stimulation to treat urinary incontinence is expected to boost the global pelvic floor stimulator market. According to a report by Future Market Insights (FMI), the global pelvic floor stimulator market was valued at US$ 110.4 Mn in 2020 and is predicted to expand at a CAGR of over 8.8% during the forecast period (2021–2031).

Weakening of pelvic floor muscles, urinary tract infections, menopause, constipation, obesity, and alcoholism are the main causes of urinary incontinence. The rising prevalence of these conditions, added to the growing elderly population, are major drivers for the global pelvic floor stimulators market.

Similarly, a high level of portability and lower costs of mobile devices in contrast to fixed devices or surgical treatments, and progressive therapeutic results and easy access to patients through over-the-counter (OTC) medical channels are expected to drive demand.

Initiatives undertaken by government and non-governmental organizations to create awareness are increasing the demand for pelvic floor stimulators. For instance, the Australian government has started a program “National Continence Management Program.”

The government of Australia also started “The continence aids payment scheme (CAPS).” COVID-19 kicked the pelvic floor stimulators demand into high gear—and this extended to consumers increasing their adoption using online sales channels. However, lack of labor, halt on transportation, and disruptions in the supply chain, has affected device availability and growth prospects for the near future.

Manufacturers are focusing on research and development activities to develop unique and technologically advanced devices with rechargeable functionality. In March 2019 InControl Medical received FDA approval for a new Attain designed for at-home use to women in the U.S. suffering from stress, urge, mixed urinary incontinence or bowel incontinence.

Request The Sample Report @

Key Takeaways from Pelvic Floor Stimulator Market Study

  • Electrical stimulators will reflect a revenue share of more than 66% with a CAGR of 9.1% owing to the high demand for treatment research for urinary incontinence.
  • Urinary Incontinence holds a share of over 75% in 2021, due to the growing geriatric population which is prone to urinary incontinence.
  • The U.K and Germany are leading markets in Europe, cumulatively accounting for over 45% of the regional value share, owing to consumer reliance on technology for health information.
  • Driven by a matured healthcare and research sector, the U.S., will account for more than 78% of the North America market by 2031.
  • China is a high potential market reflecting a 9.9% CAGR, driven by a rapidly growing consumer demographic of geriatrics.

 “Increasing prevalence of pelvic floor disorders and subsequently rising increasing awareness about the benefits electrical stimulation in the treatment of urinary incontinence are driving the adoption pelvic floor stimulators on a global scale through 2031,” says the FMI Analyst.   

Key Participant Insights

Key players in the market are focusing on strategic collaborations, acquisitions, and expansion. Furthermore, product launches, agreements and research sponsorships are key strategies adopted by manufacturers to expand their research and development capabilities, while increasing their sales by strengthening product portfolios in the pelvic floor stimulator market.

In August 2020, Medtronic expanded leadership to launch InterStim Micro Neurostimulator and InterStim SureScan MRI Leads, for treating bladder and bowel control conditions.

Want More Insights?

Future Market Insights (FMI) brings the comprehensive research report on forecast revenue growth at global, regional, and country levels that provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global pelvic floor stimulator market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the pelvic floor stimulator market on basis of product type [Electrical stimulators and Magnetic Stimulators], application (Urinary Incontinence, Sexual Dysfunction and Neurodegenerative Diseases). Based on End User [Hospitals, Ambulatory Surgical Centers and Specialized Clinics] across seven major regions.

Speak To Analyst about queries @

Key Questions Answered in Report

  • How much is the pelvic floor stimulators market worth?

The global pelvic floor stimulators market is worth US$ 118.6 Mn in the year 2021 and is expected to reach US$ 274.9 Mn by 2031 owing to the rising prevalence of pelvic floor disorders with increasing awareness for electrical stimulation to treat urinary incontinence.

  • What is the demand outlook of the pelvic floor stimulators market?

The pelvic floor stimulators market is estimated to grow at a CAGR of 8.8% during the forecast period ending in 2031.

  • What was the last 5-year CAGR for the pelvic floor stimulators market?

Historically, the market has grown at a CAGR of 4.8% from 2016 to 2020.

  • What are the key trends affecting pelvic floor stimulators market growth?

Adoption of telehealth for pelvic floor care, availability of reconstructive surgeries for POPs and rectal prolapse, high rates of overactive bladder syndrome in men, and product development and launches, are some of the key trends creating lucrative opportunities in the market.

  • What factors are driving the demand for pelvic floor stimulators market?

Growing geriatric population prone to urinary incontinence, technological advancements, and high demand for electrical stimulation to treat urinary incontinence are some of the driving factors that has bolstered the demand for pelvic floor stimulators.

  • What is the market share of the top players in the pelvic floor stimulators market?

The cumulative market share of top players including Medtronic, Zynex Inc., Chiaro Technology Ltd., and Atlantic Therapeutics constitutes around 75% of the overall market.

Request For Report TOC @

About FMI
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries:
For Media Enquiries:

Editor Details

Last Updated: 22-Oct-2021